ATE355288T1 - COMPOUNDS AND THERAPEUTIC METHODS - Google Patents

COMPOUNDS AND THERAPEUTIC METHODS

Info

Publication number
ATE355288T1
ATE355288T1 AT00926538T AT00926538T ATE355288T1 AT E355288 T1 ATE355288 T1 AT E355288T1 AT 00926538 T AT00926538 T AT 00926538T AT 00926538 T AT00926538 T AT 00926538T AT E355288 T1 ATE355288 T1 AT E355288T1
Authority
AT
Austria
Prior art keywords
compounds
therapeutic methods
treatment
diseases
methods
Prior art date
Application number
AT00926538T
Other languages
German (de)
Inventor
Rodney W Rickards
Geoffrey D Smith
Kiaran Kirk
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ0373A external-priority patent/AUPQ037399A0/en
Priority claimed from AUPQ0506A external-priority patent/AUPQ050699A0/en
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE355288T1 publication Critical patent/ATE355288T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to indolo[3,2-j]phenanthridine compounds and their use in the treatment of cancer and other diseases of humans and animals including parasitic diseases such as those of Apicomplexan origin, compositions containing said compounds and methods of treatment using them.</PTEXT>
AT00926538T 1999-05-14 2000-05-12 COMPOUNDS AND THERAPEUTIC METHODS ATE355288T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0373A AUPQ037399A0 (en) 1999-05-14 1999-05-14 Novel compounds and therapeutic methods
AUPQ0506A AUPQ050699A0 (en) 1999-05-21 1999-05-21 Novel compounds and therapeutic methods-ii

Publications (1)

Publication Number Publication Date
ATE355288T1 true ATE355288T1 (en) 2006-03-15

Family

ID=25646057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926538T ATE355288T1 (en) 1999-05-14 2000-05-12 COMPOUNDS AND THERAPEUTIC METHODS

Country Status (7)

Country Link
US (1) US6632822B1 (en)
EP (1) EP1178988B1 (en)
JP (1) JP2002544275A (en)
AT (1) ATE355288T1 (en)
CA (1) CA2372032A1 (en)
DE (1) DE60033649D1 (en)
WO (1) WO2000069856A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1819297B1 (en) 2004-09-28 2015-01-14 Atrium Medical Corporation Uv cured gel and method of making
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
JP2010508897A (en) 2006-11-06 2010-03-25 アトリウム メディカル コーポレーション Coated surgical mesh
SG175707A1 (en) * 2009-06-10 2011-12-29 Chugai Pharmaceutical Co Ltd Tetracyclic compound
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
NZ608312A (en) 2010-08-20 2015-02-27 Chugai Pharmaceutical Co Ltd Composition containing tetracyclic compound
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2014050781A1 (en) 2012-09-25 2014-04-03 中外製薬株式会社 Ret inhibitor
MX2016013735A (en) 2014-04-25 2017-03-09 Chugai Pharmaceutical Co Ltd Novel crystal of tetracyclic compound.
US10350214B2 (en) 2014-04-25 2019-07-16 Chugai Seiyaku Kabushiki Kaisha Preparation containing tetracyclic compound at high dose
TWI803187B (en) 2014-08-08 2023-05-21 日商中外製藥股份有限公司 Solid dispersion containing amorphous body of tetracyclic compound and preparation
BR112017013982A2 (en) 2015-01-16 2018-01-02 Chugai Seiyaku Kabushiki Kaisha combination drug
KR102635225B1 (en) 2018-09-04 2024-02-07 추가이 세이야쿠 가부시키가이샤 Method for producing tetracyclic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743899B2 (en) 1997-07-18 2002-02-07 Georgetown University Bicyclic metabotropic glutamate receptor ligands
US6362196B1 (en) 1999-10-29 2002-03-26 Merck & Co., Inc. Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists

Also Published As

Publication number Publication date
EP1178988A1 (en) 2002-02-13
DE60033649D1 (en) 2007-04-12
JP2002544275A (en) 2002-12-24
EP1178988B1 (en) 2007-02-28
CA2372032A1 (en) 2000-11-23
WO2000069856A1 (en) 2000-11-23
US6632822B1 (en) 2003-10-14
EP1178988A4 (en) 2004-10-06

Similar Documents

Publication Publication Date Title
ATE355288T1 (en) COMPOUNDS AND THERAPEUTIC METHODS
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60029799D1 (en) COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE
ATE339406T1 (en) CHINAZOLINE COMPOUNDS AS REMEDIES
DE60038183D1 (en) COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
ME00513B (en) Azabicycloalkanes as ccr5 modulators
TR199903331T2 (en) Farnesil protein transferase inhibitors.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
MXPA02006029A (en) Novel lipopeptides as antibacterial agents.
DE60126980D1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC ILLNESSES
MXPA02006030A (en) Lipopeptides as antibacterial agents.
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
IS6558A (en) Mixed disease treatment with vasoconstrictor
YU13301A (en) Muscarinic agonists and antagonists
ES2144054T3 (en) TRI COMPLEXES (PLATINUM).
SE0003476D0 (en) Compounds
TR200103638T2 (en) IL-8 Receptor antagonists
DE69612056T2 (en) TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT
MXPA06007007A (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours.
ATE432936T1 (en) IMIDAZOTRIAZINE COMPOUNDS USED TO TREAT CANCER DISEASES
DE69514100D1 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
ATE404550T1 (en) CHEMICAL COMPOUNDS
AU7079300A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties